Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Solid Malignancies × ZD4054 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5 Rectal Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Malignancies 1

Interventions

Irinotecan 2 vistusertib 1 sapanisertib 1 durvalumab 1 danvatirsen 1 ceralasertib 1 cediranib 1 ZD4054 1 Topotecan 1 HM781-36B 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00997945 2011-05-19

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

AstraZeneca

Phase 1 Completed

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡